惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

D
DataBreaches.Net
B
Blog
博客园_首页
C
Check Point Blog
Microsoft Security Blog
Microsoft Security Blog
MyScale Blog
MyScale Blog
P
Proofpoint News Feed
Engineering at Meta
Engineering at Meta
钛媒体:引领未来商业与生活新知
钛媒体:引领未来商业与生活新知
B
Blog RSS Feed
M
MIT News - Artificial intelligence
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
WordPress大学
WordPress大学
宝玉的分享
宝玉的分享
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
The Cloudflare Blog
量子位
V
V2EX
Y
Y Combinator Blog
Hugging Face - Blog
Hugging Face - Blog
Martin Fowler
Martin Fowler
Recent Announcements
Recent Announcements
I
InfoQ
博客园 - 【当耐特】

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Elekta AB (publ) (EKTAY) Analyst/Investor Day Transcript
SA Transcripts · 2026-06-18 · via All Articles on Seeking Alpha

Elekta AB (publ) (EKTAY) Analyst/Investor Day June 17, 2026 8:00 AM EDT

Company Participants

Peter Nyquist - Head of Investor Relations
Jakob Just-Bomholt - CEO & President
Christopher Busch - Chief Product & Technology Officer
Arnaud Delhaye
Ardie Ermers
Anming Gong
Klara Eiritz - Chief Financial Officer

Conference Call Participants

Veronika Dubajova - Citigroup Inc., Research Division
Hassan Al-Wakeel - Barclays Bank PLC, Research Division
Johan Unnerus - SB1 Markets, Sweden Branch
Ludwig Germunder - Handelsbanken Capital Markets AB, Research Division
Mattias Vadsten - SEB, Research Division
Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division
Erik Cassel - Danske Bank A/S, Research Division
David Adlington - JPMorgan Chase & Co, Research Division

Presentation

Peter Nyquist
Head of Investor Relations

So welcome, everyone, to Elekta's Capital Markets Day 2026. Welcome you here in Stockholm at [ Madison Square ] and also welcome all of you online. My name is Peter Nyquist, and I'm Head of Investor Relations since about 2 years now. So the big picture, we're going to have 3 hours of presentations. We will end with a 45-minute Q&A. And hopefully, around 3:00, we will have a break for coffee and refreshments. So that's the setup. I will go into more details later on.

But let me start with some reflections. Talking to both sell side and buy side over the last month and weeks, there are 3 areas that we hopefully will cover today that comes in mind. One is around products, one is really around growth in regions and competition. And the third one is about financial performance. So if I sort of comment each of them, if you talk about products, question we'll get a lot is Elekta competitive enough in radiotherapy to stay in the forefront, both when it comes to software as well as hardware. Hopefully, today, our CEO, our Chief Technology Officer as well as our regional managers will be able to answer that question, the uniqueness with the offering